KRM Ayurveda IPO GMP Today—Live GMP, Review & Share Price Target 2026

KRM Ayurveda IPO GMP Today:

● LIVE GMP Last Updated: January 17, 2026 | Research Desk: Positional Calls

This institutional-grade analysis covers KRM Ayurveda IPO GMP today, price band, Q3 results, technical levels, risks, and a data-backed Share Price Target 2026 (₹185–₹215).


🔹 Quick Snapshot

Metric Data
IPO Price Band ₹128 – ₹135
GMP Today ₹15 (≈ 11.1%)
Expected Listing ₹150 – ₹155
Share Price Target 2026 ₹185 – ₹215
Issue Size ₹77.49 Cr (Fresh Issue)
Listing NSE SME
Trend Bias Bullish (Long Term)
Risk Rating Medium–High (SME)

1) Fundamental Indicators: The Growth Engine

Metric FY24 FY25
Revenue ₹67.16 Cr ₹76.55 Cr
PAT ₹3.41 Cr ₹12.10 Cr (+254.84%)
Debt/Equity 1.31x (Pre-IPO)
Debt Reduction ₹12.50 Cr from IPO proceeds

Q3 Results Snapshot (FY25)

Metric Q3 FY25 YoY Change
Revenue ₹64 Cr +24%
EBITDA Margin 16.8% +120 bps
PAT ₹6.4 Cr +28%
Order Book ₹210 Cr

2) Technical & Valuation Roadmap—2026 Targets

Level Price Interpretation
Expected Listing ₹150–₹155 Based on GMP
Accumulation Zone ₹138–₹142 Post-listing support
Target 1 (2026) ₹185 Momentum breakout
Target 2 (2026) ₹215 Base case target
Stop Loss ₹125 Risk control

3) Peer Comparison

Company P/E ROE Growth Valuation
KRM Ayurveda 17.3x 67.9% High Undervalued
Jeena Sikho Lifecare ~76x Lower Medium Overvalued

4) Risk Management—Defensive Playbook

  • Geographic concentration (68% revenue from Delhi/Haryana)
  • Negative operating cash flow in FY25
  • SME liquidity risk

Risk Controls:

  • Stop Loss: ₹125
  • Entry: Staggered post-listing
  • Position Size: Max 5–8%

KRM Ayurveda IPO GMP Today—Live View

Date GMP (₹) Trend Expected Listing
17 Jan 2026 ₹15 🟢 Bullish ₹150–₹155

🔗 Internal Links


Final Verdict

Bullish for 2026—Strong growth + undervaluation + AYUSH tailwinds support the ₹185–₹215 target.

Compliance & Disclosure: Educational content only. Not SEBI-registered advice.

About The Author

More From Author

Digilogic Systems IPO GMP Today—Grey Market Premium Live Update & Expert View

Leave a Reply

Your email address will not be published. Required fields are marked *